Redpoint Investment Management’s Zimmer Biomet ZBH Stock Holding History

Redpoint Investment Management’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$517K	Sell	4,948 -1,314	-21%	-$144K	0.08%	316
2022 Q2	$658K	Hold	6,262	–	–	0.08%	306
2022 Q1	$801K	Buy	6,262 +690	+12%	+$83.2K	0.08%	298
2021 Q4	$687K	Sell	5,572 -83	-1%	-$10.9K	0.05%	381
2021 Q3	$804K	Hold	5,655	–	–	0.07%	327
2021 Q2	$883K	Sell	5,655 -193	-3%	-$31.3K	0.07%	322
2021 Q1	$909K	Hold	5,848	–	–	0.08%	300
2020 Q4	$875K	Hold	5,848	–	–	0.09%	250
2020 Q3	$773K	Sell	5,848 -9,162	-61%	-$1.2M	0.08%	256
2020 Q2	$1.74M	Sell	15,010 -1,035	-6%	-$119K	0.1%	244
2020 Q1	$1.57M	Hold	16,045	–	–	0.1%	235
2019 Q4	$2.33M	Hold	16,045	–	–	0.11%	228
2019 Q3	$2.14M	Hold	16,045	–	–	0.11%	227
2019 Q2	$1.83M	Sell	16,045 -410	-2%	-$48K	0.1%	264
2019 Q1	$2.04M	Hold	16,455	–	–	0.1%	256
2018 Q4	$1.66M	Hold	16,455	–	–	0.1%	260
2018 Q3	$2.1M	Hold	16,455	–	–	0.11%	232
2018 Q2	$1.78M	Hold	16,455	–	–	0.1%	260
2018 Q1	$1.74M	Hold	16,455	–	–	0.1%	271
2017 Q4	$1.93M	Buy	+16,455	New	+$1.86M	0.11%	248

Other funds holding ZBH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Redpoint Investment Management's ZBH Position: Q3 2022 in Review

Redpoint Investment Management reduced its Zimmer Biomet (ZBH) stake by 21% in Q3 2022, selling an estimated $144K and leaving 4,948 shares worth $517K. The position accounts for 0.08% of the portfolio, ranked #316.

Redpoint Investment Management first reported a position in ZBH in Q4 2017 and has held it in 20 quarters since. The position peaked at $2.33M in Q4 2019. 919 funds tracked by Wall St. Rank hold ZBH as of Q3 2022.

Redpoint Investment Management held 4,948 shares of Zimmer Biomet worth $517K as of Q3 2022.
Redpoint Investment Management sold 1,314 Zimmer Biomet shares in Q3 2022, an estimated $144K.
Zimmer Biomet made up 0.08% of Redpoint Investment Management's portfolio in Q3 2022, its #316 holding.
Redpoint Investment Management first reported a position in Zimmer Biomet in Q4 2017 and has held it in 20 quarters since.
Redpoint Investment Management's Zimmer Biomet position peaked at $2.33M in Q4 2019.
919 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2022.

Based on Redpoint Investment Management's 13F filing for Q3 2022, filed 14 Oct 2022.